gr 89696 has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caudle, RM; Dubner, R; Ho, J; Mannes, AJ | 1 |
Grau, JW; Maultsby, ML; Puga, DA; Washburn, SN | 1 |
Hentges, ST; Pennock, RL | 1 |
Aceves, M; Hook, MA; Mathai, BB | 1 |
4 other study(ies) available for gr 89696 and enkephalin, ala(2)-mephe(4)-gly(5)-
Article | Year |
---|---|
Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation.
Topics: Analgesics; Animals; Benzeneacetamides; Benzomorphans; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Hyperalgesia; Male; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa | 1997 |
Opioid regulation of spinal cord plasticity: evidence the kappa-2 opioid receptor agonist GR89696 inhibits learning within the rat spinal cord.
Topics: Adaptation, Physiological; Animals; Association Learning; Benzeneacetamides; Conditioning, Operant; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Male; Neuronal Plasticity; Neurons; Neurotransmitter Agents; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Spinal Cord; Spinal Cord Injuries; Thoracic Vertebrae | 2008 |
Direct inhibition of hypothalamic proopiomelanocortin neurons by dynorphin A is mediated by the μ-opioid receptor.
Topics: Analgesics, Opioid; Animals; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Hypothalamus; Mice; Mice, Knockout; Neurons; Patch-Clamp Techniques; Piperazines; Pro-Opiomelanocortin; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2014 |
Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Locomotion; Male; Morphine; Pain Measurement; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Recovery of Function; Severity of Illness Index; Spinal Cord Injuries | 2016 |